A Vancouver-based therapeutics innovator announced this week that the first patient has entered the next phase of a cancer medication trial. The medication from Sustained Therapeutics targets a rare form of cancer, Upper Tract Urethral Carcinoma. A cancer of the inside lining of the kidney, UTUC affects over 7,000 individuals annually across North America. The […]
Sustained Therapeutics
Sustained Therapeutics Announces Trial of New Drug for Chronic Scrotal Pain
A Vancouver-based therapeutics company has begun a second Phase II trial of its novel long lasting non-opioid pain medication, with a specific focus on treating Chronic Scrotal Pain (CSP), a debilitating condition estimated to affect 1% of the male population. Sustained Therapeutics’ first sustained release drug candidate, ST-01, is designed to slowly release over about […]
Sustained Therapeutics Advancing Clinical Trials for Novel Drug Delivery Platform
One in five people suffer from chronic pain at some point in their lives, but current treatments like opioids and anti-inflammatory medications have short-term activity or unwanted side effects, and can be highly addictive. A Vancouver-based therapeutics company has received regulatory approval to begin the second Phase II trial of its novel long lasting non-opioid […]
Meet The 14 Ready-to-Raise Ventures At UBC’s 2022 Investor Showcase
entrepreneurship@UBC is hosting their 2022 Investor Showcase in-person on May 10th at UBC Robson Square. From human health discoveries and technological advancements to climate solutions and social impact, UBC entrepreneurs are putting Canada on the global stage, leading ventures who are solving the most pressing challenges we face today. entrepreneurship@UBC in collaboration with the Institute […]